Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

1280 – Young Black Sexually Minoritized Men Living With HIV, Substance Use, and Syphilis Want Doxy-PEP

By Jimmy He PharmD, DScApril 18, 2025

Background Doxycycline post-exposure prophylaxis (doxy-PEP) offers a cheap and effective method for pharmacologic syphilis and chlamydia prevention among men who have sex with men but is underutilized by populations most…

1045 – DoxyPEP Counseling and Use Among PrEP Users: Cross-Sectional Survey in the Italian PrIDE Cohort

By Jimmy He PharmD, DScMarch 31, 2026

Background Doxycycline postexposure prophylaxis (DoxyPEP) patterns of counseling and uptake among European PrEP users are scarce. In Italy, no official DoxyPEP guidelines are available. Aims are to assess the prevalence…

SUBOPTIMAL IMMUNITY TO HEPATITIS A AMONG NYC MSM INITIATING PrEP OR PEP, 2016-2019

By Jimmy He PharmD, DScApril 28, 2020

Recent outbreaks of hepatitis A virus (HAV) infection among men who have sex with men (MSM) have occurred globally, nationally, and in New York City (NYC). An estimated critical immunity threshold…

ANTIBODY PROFILING IDENTIFIES NOVEL BIOMARKERS FOR DURATION OF HIV INFECTION

By Enthusiast Inc MDMarch 7, 2019

…analyzed 403 samples from 57 African women with known duration of infection (14 days to 8.7 years). Ab binding to each peptide in the VirScan library was quantified, and peptides…

Introduction to DoxyPEP: Understanding the Issues

By Jimmy He PharmD, DScApril 26, 2024

…syphilis, and gonorrhea in cisgender men and transgender women who have sex with men. One study found doxy-PEP did not reduce risk for STI in cisgender women, potentially due to…

ANTIBODY PROFILING IDENTIFIES ANTIBODY TARGETS ASSOCIATED WITH NATURAL HIV CONTROL

By Jimmy He PharmD, DScApril 22, 2021

…>3,300 peptides spanning the HIV genome. Antibody reactivity was assessed in 13 elite controllers, 27 viremic controllers, 21 non-controllers who were virally suppressed on ART, and 12 viremic non-controllers (Discovery…

PREVALENCE OF ACTIVE HEPATITIS B AMONG NEW YORK CITY MSM, PrEP AND PEP, 2016-2017

By Enthusiast Inc MDMarch 5, 2018

The CDC recommended regimen for HIV pre-exposure prophylaxis (PrEP) and post exposure prophylaxis (PEP) contain tenofovir DF (TDF)/ emtricitabine (FTC). Providing this medication to those infected with Hepatitis B virus…

HIV BIOMEDICAL PREVENTION AMONG US WOMEN: KNOWLEDGE, BELIEFS, AND PRACTICES

By Enthusiast Inc MDMarch 5, 2018

Though biomedical HIV prevention measures including post-exposure prophylaxis (PEP), pre-exposure prophylaxis (PrEP) and treatment as prevention (TasP) are now available, U.S. women’s knowledge, attitudes, and behavior (KAB) about PEP, PrEP…

553 – Targeting of HIV-Infected Clones by Cognate Peptide Stimulation and Antiproliferative Drugs

By Jimmy He PharmD, DScMarch 20, 2025

…with peptide 61. The expanded ZNF721i cells had the phenotype of proliferating (MKI67, CDT1) cytotoxic (CCL5, GZMK, NGK7) CD4+ T cells. Both paclitaxel and MMF completely abrogated peptide induced expansion…

1018 – Clinical Characteristics of Syphilis in MSM on Postexposure Prophylaxis With Doxycycline (doxy-PEP)

By Jimmy He PharmD, DScMarch 31, 2026

…a doxy-PEP program within a real-life cohort. Methods Participants were recruited between March 2023 and April 2025 in a doxy-PEP study (PRIDOX study, CROI 2025 Abstract 1275). STI screening was…

←1
23456
…7891011…
1213141516171819202122232425262728293031323334353637383940414243444546474849505152535455565758596061626364656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top